Display options
Share it on

Tetrahedron Lett. 2015 Apr 01;56(14):1794-1797. doi: 10.1016/j.tetlet.2015.02.059.

Synthesis and Investigation of Novel Spiro-isoxazolines as Anti-Cancer Agents.

Tetrahedron letters

Prasanta Das, Ann O Omollo, Lungile J Sitole, Eric McClendon, Edward J Valente, Drazen Raucher, Leslie R Walker, Ashton T Hamme

Affiliations

  1. Department of Chemistry & Biochemistry, Jackson State University 1400 J. R. Lynch St, PO Box 17910, Jackson, Ms 39217, USA.
  2. Department of Chemistry, University of Portland, Portland, OR 97203, USA.
  3. Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS, 39216, USA.

PMID: 25821250 PMCID: PMC4371604 DOI: 10.1016/j.tetlet.2015.02.059

Abstract

A series of structurally diverse 4-bromo spiro-isoxazolines possessing a variety of aromatic and aliphatic substituents at the 3 position, were synthesized through a 1,3-dipolar cycloaddition followed by intramolecular cyclization of a pendant hydroxyl or carboxylic acid group. The biochemical antiproliferative activity was evaluated

Keywords: 1,3-dipolar Cycloaddition; Bioevaluation; Regioselectivity; Spiro-isoxazolines; Stereoselective Intramolecular Cyclization

References

  1. Tetrahedron Lett. 2009 Feb 4;50(5):533-535 - PubMed
  2. CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30 - PubMed
  3. Pharmacol Ther. 2010 Feb;125(2):196-218 - PubMed
  4. J Nat Prod. 1993 Jun;56(6):907-14 - PubMed
  5. European J Org Chem. 2014 May 1;2014(13):2659-2663 - PubMed
  6. J Nat Prod. 1992 Apr;55(4):509-12 - PubMed
  7. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1055-63 - PubMed
  8. Prog Drug Res. 1998;51:185-217 - PubMed
  9. Drugs Aging. 2008;25(1):35-45 - PubMed
  10. Cancer Res. 1998 Mar 15;58(6):1195-201 - PubMed
  11. Adv Biochem Eng Biotechnol. 1999;64:101-54 - PubMed
  12. CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36 - PubMed
  13. J Nat Prod. 1999 Oct;62(10):1443-4 - PubMed

Publication Types

Grant support